[HTML][HTML] Pre-steady-state kinetics of the SARS-CoV-2 main protease as a powerful tool for antiviral drug discovery
MY Zakharova, AA Kuznetsova, VI Uvarova… - Frontiers in …, 2021 - frontiersin.org
The design of effective target-specific drugs for COVID-19 treatment has become an
intriguing challenge for modern science. The SARS-CoV-2 main protease, Mpro …
intriguing challenge for modern science. The SARS-CoV-2 main protease, Mpro …
[PDF][PDF] Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery. Front. Pharmacol. 12: 773198. doi: 10.3389/fphar …
MY Zakharova, AA Kuznetsova… - … www. frontiersin. org, 2021 - scienceopen.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in 2020 as a
novel member of the family Coronaviridae (genus Betacoronavirus)(Zhu et al., 2020a). This …
novel member of the family Coronaviridae (genus Betacoronavirus)(Zhu et al., 2020a). This …
Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery
MY Zakharova, AA Kuznetsova, VI Uvarova… - Frontiers in …, 2021 - jglobal.jst.go.jp
Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral
Drug Discovery | Article Information | J-GLOBAL Art J-GLOBAL ID:202202291974765966 …
Drug Discovery | Article Information | J-GLOBAL Art J-GLOBAL ID:202202291974765966 …
Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery.
MY Zakharova, AA Kuznetsova, VI Uvarova… - Frontiers in …, 2021 - europepmc.org
The design of effective target-specific drugs for COVID-19 treatment has become an
intriguing challenge for modern science. The SARS-CoV-2 main protease, M pro …
intriguing challenge for modern science. The SARS-CoV-2 main protease, M pro …
[PDF][PDF] Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery
MY Zakharova, AA Kuznetsova, VI Uvarova… - Front. Pharmacol. 12 …, 2021 - academia.edu
The design of effective target-specific drugs for COVID-19 treatment has become an
intriguing challenge for modern science. The SARS-CoV-2 main protease, Mpro …
intriguing challenge for modern science. The SARS-CoV-2 main protease, Mpro …
Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery
MY Zakharova, AA Kuznetsova… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
The design of effective target-specific drugs for COVID-19 treatment has become an
intriguing challenge for modern science. The SARS-CoV-2 main protease, M pro …
intriguing challenge for modern science. The SARS-CoV-2 main protease, M pro …
Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery
MY Zakharova, EN Kaliberda, IN Kurbatskaia… - Frontiers in …, 2021 - elibrary.ru
This research was supported by the RFBR Grant# 20-04-60468 as well as by State
Research Funding for FSASI “Chumakov FSC R&D IBP RAS”(Institute of Poliomyelitis) …
Research Funding for FSASI “Chumakov FSC R&D IBP RAS”(Institute of Poliomyelitis) …
[HTML][HTML] Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery
MY Zakharova, AA Kuznetsova, VI Uvarova… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
The design of effective target-specific drugs for COVID-19 treatment has become an
intriguing challenge for modern science. The SARS-CoV-2 main protease, M pro …
intriguing challenge for modern science. The SARS-CoV-2 main protease, M pro …
Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery.
MY Zakharova, AA Kuznetsova, VI Uvarova… - Frontiers in …, 2021 - europepmc.org
The design of effective target-specific drugs for COVID-19 treatment has become an
intriguing challenge for modern science. The SARS-CoV-2 main protease, M pro …
intriguing challenge for modern science. The SARS-CoV-2 main protease, M pro …